Publications
Lin NU, Winer EP, Wheatley D, Carey LA, Houston S, Mendelson D, Munster P, Frakes L, Kelly S, Garcia AA, Cleator S, Uttenreuther-Fischer M, Jones H, Wind S, Vinisko R, Hickish T. A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab. Breast cancer research and treatment. 2012. PMID: 22418700
Brufsky A, Valero V, Tiangco B, Dakhil S, Brize A, Rugo HS, Rivera R, Duenne A, Bousfoul N, Yardley DA. Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial. Breast cancer research and treatment. 2012. PMID: 22415477
Kozarewa I, Rosa-Rosa JM, Wardell CP, Walker BA, Fenwick K, Assiotis I, Mitsopoulos C, Zvelebil M, Morgan GJ, Ashworth A, Lord CJ, J C. A modified method for whole exome resequencing from minimal amounts of starting DNA. PloS one. 2012. PMID: 22403682
Timothy Churchill, Hashmi Rafeek, Suraj Rasania, Claire Mulvey, Victor Ferrari, Saurabh Jha, Karen Terembula, Scott Lilly, Luis Eraso, Muredach Reilly, Atif Qasim. CALCIFICATION OF THE ASCENDING AND DESCENDING THORACIC AORTA IDENTIFIES TWO DISTINCT PHENOTYPES IN TYPE 2 DIABETES. Journal of the American College of Cardiology. 2012. PMID:
Riess JW, Logan AC, Krupitskaya Y, Padda S, Clément-Duchêne C, Ganjoo K, Colevas AD, Pedro-Salcedo MS, Kuo CJ, Wakelee HA. Maintenance bevacizumab is associated with increased hemoglobin in patients with advanced, nonsquamous, non-small cell lung cancer. Cancer investigation. 2012. PMID: 22360362
Claire Mulvey, Nehal Mehta, M. Haris Usman, Stephen Master, Rhia Shah, Parth Patel, Christine hinkle, Rachana Shah, Jane Ferguson, Muredach Reilly. DIFFERENTIAL RELATIONS OF BASELINE AND ENDOTOXIN-INDUCED SERUM AMYLOID A LEVELS IN HUMANS. Journal of the American College of Cardiology. 2012. PMID:
Riess JW, Logan AC, Krupitskaya Y, Padda S, Clément-Duchêne C, Ganjoo K, Colevas AD, Pedro-Salcedo MS, Kuo CJ, Wakelee HA. Maintenance bevacizumab is associated with increased hemoglobin in patients with advanced, nonsquamous, non-small cell lung cancer. Cancer investigation. 2012. PMID: 22360362
Hashmi Rafeek, Suraj Rasania, Timothy Churchill, Claire Mulvey, Victor Ferrari, Saurabh Jha, Karen Terembula, Muredach Reilly, Atif Qasim, Steven Kawut. QUANTITATIVE ASSESSMENT OF MITRAL ANNULAR CALCIFICATION BY CARDIAC CT IN A DIABETIC POPULATION: ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS AND CORONARY ARTERY CALCIUM. Journal of the American College of Cardiology. 2012. PMID:
Wolf JL, Siegel D, Goldschmidt H, Hazell K, Bourquelot PM, Bengoudifa BR, Matous J, Vij R, de Magalhaes-Silverman M, Abonour R, Anderson KC, Lonial S. Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma. Leukemia & lymphoma. 2012. PMID: 22288662
Van Loon K, Venook AP. Metastatic colorectal cancer: a curable disease. Oncology (Williston Park, N.Y.). 2012. PMID: 22545312
Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, National Comprehensive Cancer Network. Melanoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2012. PMID: 22393197
Van Loon K, Venook AP. Metastatic colorectal cancer: a curable disease. Oncology (Williston Park, N.Y.). 2012. PMID: 22545312
Kelley RK, Atreya C, Venook AP, Febbo PG. Predictive biomarkers in advance of a companion drug: ahead of their time? Journal of the National Comprehensive Cancer Network : JNCCN. 2012. PMID: 22393192
Kelley RK, Atreya C, Venook AP, Febbo PG. Predictive biomarkers in advance of a companion drug: ahead of their time? Journal of the National Comprehensive Cancer Network : JNCCN. 2012. PMID: 22393192
Kelley RK, Atreya C, Venook AP, Febbo PG. Predictive biomarkers in advance of a companion drug: ahead of their time? Journal of the National Comprehensive Cancer Network : JNCCN. 2012. PMID: 22393192
Brennan K, Garcia-Closas M, Orr N, Fletcher O, Jones M, Ashworth A, Swerdlow A, Thorne H, KConFab Investigators, Riboli E, Vineis P, Dorronsoro M, Clavel-Chapelon F, Panico S, Onland-Moret NC, Trichopoulos D, Kaaks R, Khaw KT, Brown R, Flanagan JM. Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer research. 2012. PMID: 22374981
Magbanua MJ, Sosa EV, Scott JH, Simko J, Collins C, Pinkel D, Ryan CJ, Park JW. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC cancer. 2012. PMID: 22373240
Orloff MS, Zhang L, Bebek G, Eng C. Integrative genomic analysis reveals extended germline homozygosity with lung cancer risk in the PLCO cohort. PloS one. 2012. PMID: 22384118
Natrajan R, Mackay A, Lambros MB, Weigelt B, Wilkerson PM, Manie E, Grigoriadis A, A'Hern R, van der Groep P, Kozarewa I, Popova T, Mariani O, Turaljic S, Furney SJ, Marais R, Rodruigues DN, Flora AC, Wai P, Pawar V, McDade S, Carroll J, Stoppa-Lyonnet D, Green AR, Ellis IO, Swanton C, van Diest P, Delattre O, Lord CJ, Foulkes WD, Vincent-Salomon A, Ashworth A, Stern MH, Reis-Filho JS. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers. The Journal of pathology. 2012. PMID: 22362584
Postel-Vinay S, Vanhecke E, Olaussen KA, Lord CJ, Ashworth A, Soria JC. The potential of exploiting DNA-repair defects for optimizing lung cancer treatment. Nature reviews. Clinical oncology. 2012. PMID: 22330686